Multiple superficial injuries of ankle and foot

ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S90.7 Cause of death: ICD-10 — S90.7 2 out of 7 registries used, show all original rules.	46
4. Check minimum number of events None	46
5. Include endpoints None	46
6. Filter based on genotype QC (FinnGen only)	45

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_ANKLE_FOOT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S90
Name in latin: Laesiones superficiales multae tarsi/pedis

NAME	ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT
CONTROL_EXCLUDE	ST19_INJURI_ANKLE_FOOT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S907
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S907
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Multiple superficial injuries of ankle and foot based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	45	29	16
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	43.63	46.28	38.84

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2.67

2.52

3.2

2.8

77.50

27.94

ng/l

0.32

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.68

2.08

1.2

1.3

35.86

31.01

iu/ml

—

(1761868) Lipid panel - Serum or Plasma

163

0.38

1.86

1.8

2.1

—

(3022313) Gas panel - Capillary blood

4.17

1.76

5.4

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.87

1.66

1.8

2.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

158

2.09

1.60

2.8

2.6

118.71

76.28

ug/l

0.66

151

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.13

1.56

1.0

1.2

—

(3026008) Bacteria identified in Urine by Culture

2.20

1.54

1.6

2.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

152

2.03

1.49

2.6

2.3

—

(40758558) Short blood count panel - Blood

101

2.08

1.46

4.6

6.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

123

1.93

1.26

4.2

8.0

0.98

1.09

inr

—

(4200892) Spirometry reversibility

2.82

1.25

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.00

1.20

0.0

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

1.99

1.13

3.1

4.7

92.92

100.62

0.45

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.42

1.06

2.2

2.5

0.18

0.25

g/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

0.00

1.02

0.0

3.0

—

14710.03

—

(3019225) pH of Specimen

2.40

0.97

10.2

3.8

—

(3044640) Blood type and Crossmatch panel - Blood

1.87

0.97

2.2

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.96

0.92

2.3

2.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.89

0.88

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.07

0.88

1.8

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.00

0.85

2.0

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.89

0.84

1.2

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.94

0.82

5.0

2.0

25.02

26.18

—

(3013115) Eosinophils [#/volume] in Blood

187

1.59

0.76

7.6

6.9

0.19

0.17

e9/l

0.22

173

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

104

1.66

0.75

2.0

1.9

100.25

93.02

pmol/l

—

(3003694) ABO and Rh group [Type] in Blood

113

1.64

0.74

1.9

1.5

—

(3042936) Bacteria identified in Isolate by Culture

1.78

0.72

2.7

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

220

1.55

0.68

4.5

3.6

—

44.14

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

375

1.86

0.64

16.7

10.4

16.74

19.34

mg/l

0.35

278

(3000494) Fungus identified in Specimen by Culture

1.82

0.60

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

0.56

0.60

1.8

1.5

1.90

1.31

mmol/l

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

175

0.64

0.60

5.1

6.8

10.00

10.77

umol/l

0.09

169

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

317

1.62

0.60

3.9

3.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

142

0.62

0.58

2.5

2.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

370

1.62

0.48

17.3

9.7

139.55

139.81

mmol/l

0.30

359

(40760892) CBC W Ordered Manual Differential panel - Blood

171

1.42

0.48

7.1

6.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.63

0.44

2.0

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.45

0.42

2.9

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.41

0.0

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.62

0.40

1.0

1.4

—

(36304419) Bacteria [Presence] in Urine

1.43

0.39

2.9

2.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

276

1.38

0.39

5.2

4.1

14.18

14.68

pmol/l

0.56

255

(3000492) Spirometry study

1.53

0.38

1.2

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

372

1.58

0.37

17.6

9.7

3.98

3.95

mmol/l

0.26

361

(3013512) EKG study

1.43

0.33

3.8

2.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

114

1.33

0.29

2.0

1.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

252

1.28

0.28

4.6

4.1

11.29

8.35

mm/h

0.81

239

(3019832) Treponema pallidum Ab [Presence] in Serum

1.31

0.28

1.8

1.6

—

(3018095) Leukocytes [#/volume] in Urine

125

1.30

0.27

3.6

2.9

8.64

62.48

e6/l

—

(40768804) Tissue Pathology biopsy report

145

1.27

0.25

1.8

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.30

0.24

2.9

2.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.35

0.24

1.8

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.35

0.24

7.0

3.5

29.40

30.61

—

(36660697) Celiac disease serology panel - Serum

1.28

0.23

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.25

0.23

1.8

1.1

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

25.04

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.21

0.0

1.4

—

6.64

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

1.4

—

119.30

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.20

0.0

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.20

0.0

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.20

0.0

1.4

—

(3023368) Bacteria identified in Blood by Culture

1.23

0.18

4.8

4.1

—

(3044889) 12 lead EKG panel

241

0.83

0.18

3.3

2.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.19

0.18

3.1

3.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

342

1.24

0.16

6.2

4.6

1.63

1.72

mu/l

0.27

322

(3037467) Urinalysis macro (dipstick) panel - Urine

241

1.18

0.15

4.2

3.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

115

0.83

0.12

2.0

2.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

399

1.25

0.09

15.2

11.3

80.93

71.66

umol/l

0.32

399

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

112

0.86

0.08

1.7

2.2

48.30

53.06

u/l

—

105

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1.12

0.08

1.5

1.9

2.54

2.62

mg/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.87

0.07

3.0

2.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

110

1.12

0.05

2.9

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.11

0.03

2.7

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

172

1.08

0.03

3.6

4.3

0.00

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

176

0.95

0.01

2.4

3.1

0.00

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

175

0.95

0.00

2.4

3.0

0.00

estimate

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

118

1.02

0.00

3.3

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3018572) Chloride [Moles/volume] in Blood

0.00

-0.00

0.0

7.1

—

106.86

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

2.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

103.44

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

8.86

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.0

—

35.00

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

6.22

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.6

—

157.14

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

49.89

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

4.5

—

3.05

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3039000) Anion gap in Blood

0.00

-0.00

0.0

7.1

—

10.43

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

-0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

367

1.04

-0.00

3.9

3.4

1.38

1.47

mmol/l

0.83

347

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

5.0

—

25.67

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

-0.00

0.0

1.9

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

-0.00

0.0

2.4

—

4.62

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.8

—

7.48

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

67.00

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

2.48

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

-0.00

0.0

1.7

—

(3037756) Immunofixation for Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.7

—

0.96

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

0.00

-0.00

0.0

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

-0.00

0.0

2.4

—

60.38

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT – Multiple superficial injuries of ankle and foot

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Multiple superficial injuries of ankle and foot

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Multiple superficial injuries of ankle and foot (ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

LabWAS

Mortality – FinRegistry

Relationships between endpoints